search button

A novel approach to medical countermeasures against organophosphorus compound toxicity

  • Authors:
    • Tian Wang
    • Yucun Wang
    • Leiming Zhang
    • Bing Han
    • Hongbo Wang
    • Youxin Li
    • Fenghua Fu

  • View Affiliations

  • Published online on: September 25, 2013     https://doi.org/10.3892/br.2013.172
  • Pages: 901-906
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The toxicity of organophosphorus compounds (OPs) results primarily from the irreversible inhibition of acetylcholinesterase (AChE). Huperzine A (HupA) is a reversible inhibitor of AChE and HupA sustained‑release microspheres (HSMs) steadily release HupA, resulting in the continual inhibition of AChE activity for 14 days in mice. The present study aimed to investigate the preventive effects of HSMs on the toxicity of methyl parathion (MP). The mice were pretreated with HSMs followed by MP exposure. Subsequently, the median lethal dose (LD50) and survival of the mice were determined. a histopathological examination of the brain, liver, lungs, heart, kidneys and intercostal muscles was also performed. The results revealed that the LD50 was 51.4 mg/kg in the control group and 70.0, 67.5, 63.4 and 53.5 mg/kg at 2 h, 5, 10 and 15 days after pretreatment with HSMs, respectively. pretreatment with HSMs at 2 h, 5 days and 10 days prior to an acute challenge with 1.2 x LD50 MP was sufficient to counteract the lethality and acute toxicity of MP. HSM pretreatment also attenuated the pulmonary edema induced by MP. The results demonstrated that pretreatment with HSMs may be an effective method to counteract MP poisoning. To the best of our knowledge, the present study was the first to demonstrate that pretreatment with an AChE reversible inhibitor sustained‑release agent may be a novel approach to effective protection against OP toxicity.
View Figures
View References

Related Articles

Journal Cover

November-December 2013
Volume 1 Issue 6

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.3
  • Ranked
    (total number of cites)
  • CiteScore: 4.1
  • CiteScore Rank: Q1: #19/80 Pharmacology, Toxicology and Pharmaceutics
  • Source Normalized Impact per Paper (SNIP): 0.7
  • SCImago Journal Rank (SJR): 0.514
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Wang T, Wang Y, Zhang L, Han B, Wang H, Li Y and Fu F: A novel approach to medical countermeasures against organophosphorus compound toxicity. Biomed Rep 1: 901-906, 2013.
APA
Wang, T., Wang, Y., Zhang, L., Han, B., Wang, H., Li, Y., & Fu, F. (2013). A novel approach to medical countermeasures against organophosphorus compound toxicity. Biomedical Reports, 1, 901-906. https://doi.org/10.3892/br.2013.172
MLA
Wang, T., Wang, Y., Zhang, L., Han, B., Wang, H., Li, Y., Fu, F."A novel approach to medical countermeasures against organophosphorus compound toxicity". Biomedical Reports 1.6 (2013): 901-906.
Chicago
Wang, T., Wang, Y., Zhang, L., Han, B., Wang, H., Li, Y., Fu, F."A novel approach to medical countermeasures against organophosphorus compound toxicity". Biomedical Reports 1, no. 6 (2013): 901-906. https://doi.org/10.3892/br.2013.172